Durability and outcomes of fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with moderate to severe inflammatory bowel disease.|https://dx.doi.org/10.5217/ir.2023.00100
Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015-2019: The RECUR England study.|https://dx.doi.org/10.1016/j.ijid.2024.01.002
Dissecting mechanisms of fecal microbiota transplantation efficacy in disease.|https://dx.doi.org/10.1016/j.molmed.2023.12.005
Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study.|https://dx.doi.org/10.1093/cid/ciae007
Comparative Effectiveness of Fidaxomicin vs Vancomycin in Populations With Immunocompromising Conditions for the Treatment of Clostridioides difficile Infection: A Single-Center Study.|https://dx.doi.org/10.1093/ofid/ofad622
Unlocking Bevacizumab's Potential: rCBV(max) as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients.|https://dx.doi.org/10.3390/cancers16010161
Clostridioides difficile Infection in Hospitalized Patients-A Retrospective Epidemiological Study.|https://dx.doi.org/10.3390/healthcare12010076
Generalisability of predictive models for Clostridioides difficile infection, severity, and recurrence at an urban safety-net hospital.|https://dx.doi.org/10.1016/j.jhin.2024.01.001
Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection.|https://dx.doi.org/10.1007/s40121-023-00907-w
Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence.|https://dx.doi.org/10.1007/s10096-024-04762-6
Efficacy of noncarbapenem therapy for the treatment of ceftriaxone-resistant Enterobacterales outside the urinary tract.|https://dx.doi.org/10.1017/ash.2023.137
Pyrin Inflammasome Activation Defines Colchicine-Responsive SURF Patients from FMF and Other Recurrent Fevers.|https://dx.doi.org/10.1007/s10875-023-01649-7
